Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: A nationwide study

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 4, 2012, Pages 428-434

  Kristensen, Søren Lund ^a   Fosbøl, Emil L ^a,b   Kamper, Anne Lise ^c   Køber, Lars ^c   Hommel, Kristine ^c   Lamberts, Morten ^a   Abildstrøm, Steen Z ^d   Blicher, Thalia M ^d   Torp Pedersen, Christian ^a   Gislason, Gunnar H ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c University of Copenhagen   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

Author keywords

End stage kidney disease; Nationwide; NSAIDs; Pharmacoepidemiology; Renal dialysis

Indexed keywords

ACICLOVIR; CELECOXIB; DICLOFENAC; IBUPROFEN; LITHIUM; MESALAZINE; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; ROFECOXIB;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL CLASSIFICATION; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE REGISTRY; FEMALE; HEART ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT DURATION;

AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMORBIDITY; DENMARK; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; REGISTRIES; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 84859699629     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3227     Document Type: Article

References (25)

1. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl 1999; 56: 18-24.
2. Fosbol EL, Gislason GH, Jacobsen S, et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf 2008; 17: 822-833.
3. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of Nonsteroidal Antiinflammatory Drugs. An Update for Clinicians. A Scientific Statement From the American Heart Association. Circulation 2007; 115: 1634-1642.
4. House AA, Silva Oliveira S, Ronco C. Anti-inflammatory drugs and the kidney. Int J Artif Organs 2007; 30: 1042-1046.
5. Weir MR. Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 2002; 69(Suppl 1): SI53-SI58.
6. Allon M, Pasque CB, Rodriguez M. Acute effects of captopril and ibuprofen on proteinuria in patients with nephrosis. J Lab Clin Med 1990; 116: 462-468.
7. Allon M, Pasque CB, Rodriguez M. Interaction of captopril and ibuprofen on glomerular and tubular function in humans. Am J Physiol 1990; 259: F233-F238.
8. Heeg JE, de Jong PE, Vriesendorp R, de Zeeuw D. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Am J Nephrol 1990; 10(Suppl 1): 94-97.
9. Fosbol EL, Gislason GH, Jacobsen S, et al. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2009; 85: 190-197.
10. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009; 169: 141-149.
11. Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med 2007; 120: 280 e1-280 e7.
12. Nephrology, DSo. Danish Registry of Nephrology., 2011.
13. Hommel K, Rasmussen S, Madsen M, Kamper AL. The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant 2010; 25: 947-951.
14. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-448.
15. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
16. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006; 27: 1153-1158.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
18. Schjerning Olsen AM, Fosbol EL, Lindhardsen J, et al. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation 2011; 123: 2226-2235.
19. Ofman JJ, MacLean CH, Straus WL, et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol 2002; 29: 804-812.
20. Green RE, Taggart MA, Senacha KR, et al. Rate of decline of the oriental white-backed vulture population in India estimated from a survey of diclofenac residues in carcasses of ungulates. PLoS One 2007; 2: e686.
21. Heeg JE, de Jong PE, de Zeeuw D. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action. Clin Sci (Lond) 1991; 81: 367-372.
22. Zhang J, Ding EL, Song Y. Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of Randomized Trials. JAMA 2006; 296(13): jrv60015.
23. Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004; 364: 2021-2029.
24. Brandes A, et al. The national cardiological treatment guidelines, Danish Society of cardiologists 2010.
25. Mitch WE, Walser M, Buffington GA, Lemann J, Jr. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2: 1326-1328.